This content is only available via PDF.
Skip Nav Destination
Article navigation
Review Article|
October 1992
Reversal of Neuromuscular Blockade
David R. Bevan, M.B., M.R.C.P., F.F.A.R.C.S.;
David R. Bevan, M.B., M.R.C.P., F.F.A.R.C.S.
*Professor and Head, Department of Anesthesia, Vancouver General Hospital and University of British Columbia
Search for other works by this author on:
François Donati, M.D., Ph.D., F.R.C.P.C.;
François Donati, M.D., Ph.D., F.R.C.P.C.
†Associate Professor, Department of Anesthesia, Royal Victoria Hospital and McGill University
Search for other works by this author on:
Aaron F. Kopman, M.D.
Aaron F. Kopman, M.D.
‡Associate Professor of Clinical Anesthesiology, State University of New York School of Medicine at Stony Brook
Search for other works by this author on:
Anesthesiology October 1992, Vol. 77, 785–805.
Citation
David R. Bevan, François Donati, Aaron F. Kopman; Reversal of Neuromuscular Blockade. Anesthesiology 1992; 77:785–805 doi: https://doi.org/10.1097/00000542-199210000-00025
Download citation file:
Citing articles via
Most Viewed
Related Articles
Reversal of Rocuronium-induced Neuromuscular Blockade with Sugammadex in Pediatric and Adult Surgical Patients
Anesthesiology (February 2009)
2023 American Society of Anesthesiologists Practice Guidelines for Monitoring and Antagonism of Neuromuscular Blockade: A Report by the American Society of Anesthesiologists Task Force on Neuromuscular Blockade
Anesthesiology (January 2023)
Enzymatic Versus Pharmacologic Antagonism of Profound Mivacurium-induced Neuromuscular Blockade
Anesthesiology (May 1996)
Accelerometry of Adductor Pollicis Muscle Predicts Recovery of Neuromuscular Blockade in Anesthetized Patients
Anesthesiology (June 2003)
Enzymatic Antagonism of Mivacurium-induced Neuromuscular Blockade by Human Plasma Cholinesterase
Anesthesiology (October 1995)